Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus

Item

http://www.wikidata.org/entity/Q27021622

Q27021622

about

Antiviral Treatment Guidelines for Middle East Respiratory Syndrome Preventing stem cell transplantation-associated viral infections using T-cell therapy Antiviral T-cell therapy Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Contributing and Terminating Factors of a Large RSV Outbreak in an Adult Hematology and Transplant Unit.The role of multiplex PCR in respiratory tract infections in children.The human polyomaviruses KI and WU: virological background and clinical implications.Predictive value of testing nasopharyngeal samples for respiratory viruses in the setting of lower respiratory tract disease.Clinical outcomes associated with respiratory virus detection before allogeneic hematopoietic stem cell transplant.Outcomes of hematopoietic SCT recipients with rhinovirus infection: a matched, case-control study How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation Laboratory Diagnosis of Infections in Cancer Patients: Challenges and Opportunities.Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation.Lower Respiratory Tract Diseases Caused by Common Respiratory Viruses among Stem Cell Transplantation Recipients: A Single Center Experience in Korea.Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease.Parainfluenza virus lower respiratory tract disease after hematopoietic cell transplant: viral detection in the lung predicts outcome Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO).Oral Ribavirin for the Treatment of Noninfluenza Respiratory Viral Infections: A Systematic Review.Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization.How to manage lung infiltrates in adults suffering from haematological malignancies outside allogeneic haematopoietic stem cell transplantation.Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis.Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: A systematic review.Compassionate use experience with high-titer respiratory syncytical virus (RSV) immunoglobulin in RSV-infected immunocompromised persons.Antiviral therapy for respiratory viral infections in immunocompromised patients.Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies.Respiratory virus infection after allogeneic hematopoietic stem cell transplant in a tropical center: Predictive value of the immunodeficiency scoring index.A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study.Human Metapneumovirus Infection in Immunocompromised Patients.Oral ribavirin therapy for respiratory syncytial virus infections in moderately to severely immunocompromised patients.The clinical and phylogenetic investigation for a nosocomial outbreak of respiratory syncytial virus infection in an adult hemato-oncology unit.Burden of human metapneumovirus infections in patients with cancer: Risk factors and outcomes.Epidemiology and Immediate Indirect Effects of Respiratory Viruses in Lung Transplant Recipients: A 5-Year Prospective Study.Universal Mask Usage for Reduction of Respiratory Viral Infections After Stem Cell Transplant: A Prospective Trial.BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation.Outbreak of respiratory syncytial virus (RSV) infection in immunocompromised adults on a hematology ward.Comparing Luminex NxTAG-Respiratory Pathogen Panel and RespiFinder-22 for multiplex detection of respiratory pathogens.Respiratory Syncytial Virus in Hematopoietic Stem Cell Transplantation and Solid-Organ Transplantation.Respiratory syncytial virus infection in older adults: an under-recognized problem.Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital.Oxygen-free days in hematopoietic cell transplant recipients with respiratory syncytial virus.

P2860

Q26781374-AD8F5F92-4CAD-47C7-9555-F2B244AB939F Q26801365-76A7E040-0649-4109-95A0-B4805091BC4E Q27028006-31D631D8-FACB-41A3-A1DE-95B3A0E3F453 Q30608976-5B17DCA7-A791-4F16-B7CF-23C6DCC341E4 Q34214867-FBB42A09-1944-406C-B073-08FDAA5650B1 Q34349410-B24A63B7-88B9-4A1A-AFA5-60F4C76FCCAA Q34351951-34644AFB-7EF2-4C2B-8D4D-D3C3D8FD03DF Q35036056-0E0AD37D-0892-4611-9B26-EFAEA546F187 Q36049012-3BEE1691-59D3-491E-B1FB-1613FB1ADD20 Q36164812-2C334AAC-7926-47B7-960E-8091106768AA Q36965855-565347EC-5609-4E93-A067-182724925943 Q37363377-1D9D46B1-6E06-4442-8432-45CCFADA0B09 Q37426542-14067B81-C981-4F99-9C25-2CA6819675C5 Q37622157-5FA65A61-99A5-440D-A74E-7FAE48AE69DC Q37671949-C2581CA3-D7BA-4958-9E9D-A406694982CF Q37726073-91C3B6D5-1E72-421B-8C8F-B9A81DF0CEA2 Q38207933-77F52758-900D-482C-A496-3D0FB244474E Q38558150-717E0EF2-2B2F-416D-8773-98E480EE5327 Q38613285-B40A2954-6ED7-4354-8CED-C7F15B3A178A Q38686517-344D6678-F42E-4510-B853-A15FA3A655E1 Q38797541-41D1DDAB-8DC3-4C69-ADFE-AEC133CB619F Q38853701-37091095-FFE4-4900-8F56-A61E657F05BF Q39038875-0D7F138D-4292-44A0-8DB7-4B3DDA5CFF3A Q39076394-8CB45F82-2578-4F57-B56B-F0C6BF3953BE Q39193577-19231C75-0236-447E-8B4E-C3BC78C9B5AD Q39574491-BBFE84B8-7D20-423A-B7F0-76CE2B59256B Q40055495-DC4EECE9-1770-448A-BF68-E786A5A04C7F Q40080165-FF478742-054B-4C54-BB6A-44486C61E7F3 Q40214692-6070CC83-0022-4329-9112-B8731925CBC9 Q40316430-F0913101-7364-4064-B03E-9691F3057F5C Q40340012-7456B58F-827F-4C0A-9EBD-76751F2B7FA1 Q40544268-7803669B-FA3C-4D2D-971A-6D54A52056F3 Q40591951-025B50CA-E0B9-41FE-A7F2-D7BD519EC03B Q40721939-DBF50461-37A5-4C77-B070-C7BEBC580A67 Q40750463-2E5E01EA-1950-4AB3-9226-B72ED54072EF Q40800132-D46C2CB1-2D52-4209-A094-D32F07C316A2 Q41166298-33A283BA-B578-441B-9ADE-00BA0E8637F0 Q41349182-602193AE-8AAA-4A1B-833D-2F047FBD307D Q41610012-18189AB2-F172-45E7-B7D7-1B0DB26E35DA Q41927841-207ECAF7-88D5-4119-A4C6-0A95812561EB

P2860

Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus

Item

http://www.wikidata.org/entity/Q27021622

description

2013 nî lūn-bûn

@nan

2013 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu